Nephros Inc (NEPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -275 | -458 | -169 | -1,575 | -921 |
| Depreciation Amortization | 102 | 69 | 34 | 214 | 163 |
| Accounts receivable | -195 | -382 | -22 | -221 | -171 |
| Other Working Capital | -1,924 | -980 | -723 | 830 | 1,040 |
| Other Operating Activity | 496 | 578 | 208 | 1,579 | 953 |
| Operating Cash Flow | $-1,796 | $-1,173 | $-672 | $827 | $1,064 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -50 | -50 | N/A | -75 | N/A |
| Investing Cash Flow | $-50 | $-50 | $N/A | $-75 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -4 | -4 | -2 | -79 | -76 |
| Financing Cash Flow | $-4 | $-4 | $-2 | $-79 | $-76 |
| Beginning Cash Position | 4,307 | 4,307 | 4,307 | 3,634 | 3,634 |
| End Cash Position | 2,457 | 3,080 | 3,633 | 4,307 | 4,622 |
| Net Cash Flow | $-1,850 | $-1,227 | $-674 | $673 | $988 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,796 | -1,173 | -672 | 827 | 1,064 |
| Capital Expenditure | -55 | -55 | N/A | -75 | N/A |
| Free Cash Flow | -1,851 | -1,228 | -672 | 752 | 1,064 |